In NASH with liver fibrosis, resmetirom improved NASH resolution and reduced fibrosis at 1 y
Maria Mironova(National Institutes of Health), Averell H. Sherker(National Institutes of Health)
Cited by 6
Related Papers
Outcomes in Adults With Acute Liver Failure Between 1998 and 2013
|Annals of Internal Medicine|2016|383
Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.
|Diabetes|2000|97
Hepatitis B Vaccine: Four Decades on
|Vaccines|2024|26
Granulomatous liver diseases
|Hepatology Communications|2024|25
Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies
|Current Hepatology Reports|2024|15